Clinical Trial Update: Study to Evaluate the Safety and Efficacy of Sirolimus, in Subject With Refractory Solid Tumors [Phase 4]

View source ↗

Summary

A Phase 4 trial assessing the safety and efficacy of sirolimus in subjects with refractory solid tumors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• Sirolimus (Sirolimus)

Snippet

Sponsor: Samsung Medical Center | Conditions: Refractory Solid Tumors | Phase 4 | Status: COMPLETED